| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.6 | 5e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |